2021
30. Franceschini, N., Gaeta, R., Krimpenfort, P., Briaire-de Bruijn, I., Kruisselbrink, A.B., Szuhai, K., Palubeckaitė, I., Cleton-Jansen, A.-M., and Bovée, J.V.M.G. (2021). A murine mesenchymal stem cell model for initiating events in osteosarcomagenesis points to CDK4/CDK6 inhibition as a therapeutic target. Lab Invest.
2020
29. Egeland, NG., Jonsdottir, K., Lauridsen, KL., Skaland, I., Hjorth, CF., Gudlaugsson, EG., Hamilton-Dutoit, S., Lash, TL., Cronin-Fenton, D., and Janssen, EAM. (2020). Digital Image Analysis of Ki-67 Stained Tissue Microarrays and Recurrence in Tamoxifen-Treated Breast Cancer Patients. DovePress, July 2020
28. Shipitsin, M., Giladi, E., Small III, C., Nifong, T., Dunyak, J., and Blume-Jensen, P. (2020). Tumor Markers FUS, SMAD4, DERL1, YBX1, PS6, PDSS2, CUL2, and HSPA9 for Analyzing Prostate Tumor Samples. FPO, May 2020
2019
27. Coltharp, C., PhD, Remeniuk, B. PhD, Wang, C., Schaefer, R., Liu, L., Milton, G., Duckworth, V., McLane, M., Miller, P., and Zheng, Y. (2019). P31 Applying multispectral unmixing and spatial analyses to explore tumor heterogeneity with a pre-optimized 7-color immuno-oncology workflow. Journal for ImmunoTherapy of Cancer, November 2019
2018
26. Błochowiak, K., Sokalski, J., Golusińska, E., Trzybulska, D., Witmanowski, H., Bodnar, M., and Marszałek, A. (2018). Salivary levels and immunohistochemical expression of selected angiogenic factors in benign and malignant parotid gland tumours. Clin Oral Invest 1–12.
25. Brantley, K.D., Kjærsgaard, A., Cronin-Fenton, D., Yacoub, R., Nielsen, A.S., Lauridsen, K.L., Hamilton-Dutoit, S., and Lash, T.L. (2018). Stanniocalcin Expression as a Predictor of Late Breast Cancer Recurrence. Cancer Epidemiol Biomarkers Prev.
24. Chauvin, A., Wang, C.-S., Geha, S., Garde-Granger, P., Mathieu, A.-A., Lacasse, V., and Boisvert, F.-M. (2018). The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature. Clinical Proteomics 15, 16.
23. Toth, L., Nagy, B., Mehes, G., Laszlo, E., Molnar, P.P., Poka, R., and Hernadi, Z. (2018). Cell adhesion molecule profiles, proliferation activity and p53 expression in advanced epithelial ovarian cancer induced malignant ascites—Correlation of tissue microarray and cytology microarray. Pathology – Research and Practice 214, 978–985.
2017
22. Scheel, A.H., Baenfer, G., Baretton, G., Dietel, M., Diezko, R., Henkel, T., Heukamp, L.C., Jasani, B., Jöhrens, K., Kirchner, T., et al. (2017). Interlaboratory concordance of PD-L1 immunohistochemistry for non-small-cell lung cancer. Histopathology 72, 449–459.
2016
21. Butz, H., Németh, K., Czenke, D., Likó, I., Czirják, S., Zivkovic, V., Baghy, K., Korbonits, M., Kovalszky, I., Igaz, P., et al. (2016). Systematic Investigation of Expression of G2/M Transition Genes Reveals CDC25 Alteration in Nonfunctioning Pituitary Adenomas. Pathol. Oncol. Res. 1–9.
20. Adriaens, C., Standaert, L., Barra, J., Latil, M., Verfaillie, A., Kalev, P., Boeckx, B., Wijnhoven, P.W.G., Radaelli, E., Vermi, W., et al. (2016). p53 induces formation of NEAT1 lncRNA-containing paraspeckles that modulate replication stress response and chemosensitivity. Nat. Med. 22, 861–868.
2015
19. Goos, J.A.C.M., de Cuba, E.M.V., Coupé, V.M.H., Diosdado, B., Delis-Van Diemen, P.M., Karga, C., Beliën, J.A.M., Menke-Van der Houven van Oordt, C.W., Geldof, A.A., Meijer, G.A., et al. (2015). Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis: Ann. Surg. 1.
2014
18. Chang, H., Peluso, D., Hussain, S., Shipitsin, M., and Blume-Jensen, P. (2014). Optimizing tissue microarray construction procedure to improve quality of sections. J. Histotechnol. 37, 95–100.
17. Hajnalka Rajnai, Ivett Teleki, Gergo Kiszner, Nora Meggyesházi, Peter Balla, Tamas Vancsik, Györgyi Műzes,Judit Csomor, András Matolcsy, and Tibor Krenács (2014). Connexin 43 communication channels in follicular dendritic cell development and in follicular lymphomas. J. of Immunology Res. In Press
2013
16. De Graaff, M.A., Cleton-Jansen, A.-M., Szuhai, K., and Bovée, J.V.M.G. (2013). Mediator complex subunit 12 exon 2 mutation analysis in different subtypes of smooth muscle tumors confirms genetic heterogeneity. Hum. Pathol. 44, 1597–1604.
15. Ohtomo, R., Mori, T., Shibata, S., Tsuta, K., Maeshima, A.M., Akazawa, C., Watabe, Y., Honda, K., Yamada, T., Yoshimoto, S., et al. (2013). SOX10 is a novel marker of acinus and intercalated duct differentiation in salivary gland tumors: a clue to the histogenesis for tumor diagnosis. Mod. Pathol. 26, 1041–1050.
14. Chaisuparat, R., Yodsanga, S., Montaner, S., and Jham, B.C. (2013). Activation of the Akt/mTOR pathway in dentigerous cysts, odontogenic keratocysts, and ameloblastomas. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 116, 336–342.
13. Giorgio, E.D., Clocchiatti, A., Piccinin, S., Sgorbissa, A., Viviani, G., Peruzzo, P., Romeo, S., Rossi, S., Tos, A.P.D., Maestro, R., et al. (2013). MEF2 Is a Converging Hub for Histone Deacetylase 4 and Phosphatidylinositol 3-Kinase/Akt-Induced Transformation. Mol. Cell. Biol. 33, 4473–4491.
12. Goos, J. a. C.M., Coupe, V.M.H., Diosdado, B., Delis-Van Diemen, P.M., Karga, C., Beliën, J. a. M., Carvalho, B., van den Tol, M.P., Verheul, H.M.W., Geldof, A.A., et al. (2013). Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis. Br. J. Cancer 109, 2445–2452.
11. Van Oosterwijk, J.G., Meijer, D., van Ruler, M.A.J.H., van den Akker, B.E.W.M., Oosting, J., Krenács, T., Picci, P., Flanagan, A.M., Liegl-Atzwanger, B., Leithner, A., et al. (2013). Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGFβ as Potential Targets. Am. J. Pathol. 182, 1347–1356.
2012
10. Bignotti, E., Zanotti, L., Calza, S., Falchetti, M., Lonardi, S., Ravaggi, A., Romani, C., Todeschini, P., Bandiera, E., Tassi, R.A., et al. (2012). Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma. BMC Clin. Pathol. 12, 22.
9. Rajnai, H., Bödör, C., Balogh, Z., Gagyi, É., Csomor, J., Krenács, T., Tóth, E., and Matolcsy, A. (2012). Impact of the reactive microenvironment on the bone marrow involvement of follicular lymphoma. Histopathology60, E66–E75.
8. Laurinavicius, A., Laurinaviciene, A., Ostapenko, V., Dasevicius, D., Jarmalaite, S., and Lazutka, J. (2012). Immunohistochemistry profiles of breast ductal carcinoma: factor analysis of digital image analysis data. Diagn. Pathol. 7, 27.
7. Rossing, H.H., Talman, M.-L.M., Lænkholm, A.-V., and Wielenga, V.T. (2012). Implementation of TMA and digitalization in routine diagnostics of breast pathology. APMIS 120, 341–347.
2011
6. Tamás, L., Szentkúti, G., Erős, M., Dános, K., Brauswetter, D., Szende, B., Zsákovics, I., and Krenács, T. (2011). Differential Biomarker Expression in Head and Neck Cancer Correlates with Anatomical Localization. Pathol. Oncol. Res. 17, 721–727.
5. Balla, P., Moskovszky, L., Sapi, Z., Forsyth, R., Knowles, H., Athanasou, N.A., Szendroi, M., Kopper, L., Rajnai, H., Pinter, F., et al. (2011). Epidermal growth factor receptor signalling contributes to osteoblastic stromal cell proliferation, osteoclastogenesis and disease progression in giant cell tumour of bone. Histopathology 59, 376–389.
4. Meijer, D., Gelderblom, H., Karperien, M., Cleton-Jansen, A.-M., Hogendoorn, P.C., and Bovée, J.V. (2011). Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo. Clin. Sarcoma Res. 1, 5.
2010
3. Alberghini, M., Kliskey, K., Krenacs, T., Picci, P., Kindblom, L., Forsyth, R., and Athanasou, N.A. (2010). Morphological and immunophenotypic features of primary and metastatic giant cell tumour of bone. Virchows Arch. 456, 97–103.
2. Krenacs, T., Ficsor, L., Varga, S.V., Angeli, V., and Molnar, B. (2010). Digital Microscopy for Boosting Database Integration and Analysis in TMA Studies. In Tissue Microarrays, R. Simon, ed. (Humana Press), pp. 163–175.
1. Francz, M., Egervari, K., Kardos, L., Toth, J., Nemes, Z., Szanto, J., and Szollosi, Z. (2010). Comparison of Pathvysion and Poseidon HER2 FISH assays in measuring HER2 amplification in breast cancer: a validation study. J. Clin. Pathol. 63, 341–346.
